Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Hand Function after Distal Radial Access: Is it Safe?

The benefit of the transradial approach in percutaneous interventions is well known. Its main limitation is radial artery occlusion (RAO) which would compromise the artery for future use in percutaneous procedures. Even though it is clinically silent, reported cases might reach 33%. 

Función de la mano luego del acceso radial distal, ¿es seguro?

More recently, the distal radial access (DRA) has surged as an alternative to reduce RAO. However, its safety and potential to produce negative effects in hand function have not been studied yet. 

The aim of this prospective, multicenter, cohort study was to assess hand function at long term in patients treated with DRA for coronary procedures. 

Multiple outcomes were presented to assess hand dysfunction, including coordination questionnaires, dexterity, strength, and sensation tests up to 12-month followup. 

The study looked at 313 patients. Mean age was 66 and they were mostly men. 22% presented prior radial access. As regards procedure characteristics, 54% of DRA was left, ultrasound was used to guide puncture in 85 % of cases, and they were mostly diagnostic procedures. DRA failed in 2.9% of cases. 

Read also: FFR and IFR: Are We Talking About the Same Thing?

DRA showed no hand function deterioration according to the questionnaires for subjective and objective assessment and was even associated to less pain and <1% RAO rate.  

Conclusion 

The distal radial access was not associated with worse hand function. On the contrary, it was associated to lower complications rate with good tolerance to the procedure. 

Dr. Andrés Rodríguez
Member of the editorial board of SOLACI.org.

Original Title: International Hand Function Study Following Distal Radial Access The RATATOUILLE Study.

Reference: Gregory A. Sgueglia, MD et al J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...